Edition:
India

Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

5.83USD
14 Dec 2018
Change (% chg)

$-0.12 (-2.02%)
Prev Close
$5.95
Open
$5.90
Day's High
$5.90
Day's Low
$5.62
Volume
89,927
Avg. Vol
78,356
52-wk High
$6.49
52-wk Low
$1.46

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.06 December 15 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 -- -- --
(2) OUTPERFORM 2 -- -- --
(3) HOLD 0 -- -- --
(4) UNDERPERFORM 0 -- -- --
(5) SELL 0 -- -- --
No Opinion 0 -- -- --
Mean Rating 2.00 -- -- --

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2 10.96 10.99 10.92 --
Quarter Ending Mar-19 2 12.48 12.85 12.10 --
Year Ending Dec-18 2 40.94 40.98 40.91 --
Year Ending Dec-19 2 55.68 59.40 51.96 --
Earnings (per share)
Quarter Ending Dec-18 1 -0.06 -0.06 -0.06 --
Quarter Ending Mar-19 2 -0.05 -0.04 -0.05 --
Year Ending Dec-18 1 -0.30 -0.30 -0.30 --
Year Ending Dec-19 2 -0.12 -0.10 -0.14 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-17 6.50 6.10 0.40 6.20
Quarter Ending Dec-16 5.50 5.79 0.29 5.33
Quarter Ending Mar-16 3.24 4.38 1.14 35.09
Quarter Ending Dec-15 3.52 3.05 0.46 13.19
Quarter Ending Sep-15 3.42 2.68 0.74 21.60

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 10.96 -- -- -- --
Quarter Ending Mar-19 12.48 -- -- -- --
Year Ending Dec-18 40.94 -- -- -- --
Year Ending Dec-19 55.68 -- -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 -- -- -- --
Quarter Ending Mar-19 -- -- -- --
Year Ending Dec-18 -- -- -- --
Year Ending Dec-19 -- -- -- --
Earnings